Satellos Bioscience Inc. Common Stock (MSLE) — Financial Flexibility Index
Satellos Bioscience Inc. Common Stock (MSLE) has a Financial Flexibility Index of -1.77x as of December 2025. Free cash flow of $-7.26 Million (operating CF $-7.26 Million minus capex $0.00) represents -2% of total liabilities ($4.11 Million). Check Satellos Bioscience Inc. Common Stock strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Satellos Bioscience Inc. Common Stock Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for Satellos Bioscience Inc. Common Stock across 5 annual periods. See Satellos Bioscience Inc. Common Stock (MSLE) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Satellos Bioscience Inc. Common Stock (2021–2025)
Year-by-year free cash flow to debt coverage for Satellos Bioscience Inc. Common Stock. For the full company profile including market capitalisation, see market value of Satellos Bioscience Inc. Common Stock.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -5.75x | $-23.59 Million | $-23.60 Million | $4.11 Million | ▼ -18.6% |
| 2024 | -4.84x | $-17.40 Million | $-17.40 Million | $3.59 Million | ▼ -51.8% |
| 2023 | -3.19x | $-8.72 Million | $-8.73 Million | $2.73 Million | ▼ -56.3% |
| 2022 | -2.04x | $-4.26 Million | $-4.26 Million | $2.09 Million | ▲ +14.5% |
| 2021 | -2.39x | $-3.94 Million | $-3.95 Million | $1.65 Million | — |